Is the weight-loss drug boom moving past the Ozempic era?

Novo Nordisk’s new Wegovy pill is showing signs that consumers want easier ways to take GLP-1 medications.

[Photos: Adobe Stock]

Sales are booming for Novo Nordisk’s new weight-loss pill. 

In its first earnings report since the release of an alternative to its hit GLP-1 shot, Novo Nordisk’s outlook is looking a bit brighter. The company, which now makes Wegovy in pill form, raised its guidance for the year in light of the first quarter’s........

© Fast Company